These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 211147)

  • 41. Urinary excretion and circadian rhythm of cyclic-AMP and cyclic-GMP in childhood.
    Castellote MC; Barberá G; Torralba A
    Rev Esp Fisiol; 1981 Dec; 37(4):403-6. PubMed ID: 6280254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioimmunoassay for adenosine 3', 5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in human blood, urine, and cerebrospinal fluid.
    Goldberg ML
    Clin Chem; 1977 Mar; 23(3):576-80. PubMed ID: 189955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema.
    Kuchel O; Hamet P; Cuche JL; Tolis G; Fraysse J; Genest J
    J Clin Endocrinol Metab; 1975 Aug; 41(2):282-9. PubMed ID: 169278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion.
    Barton JR; Sibai BM; Ahokas RA; Whybrew WD; Mercer BM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):931-4. PubMed ID: 1329514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose theophylline increases urine output in diuretic-dependent critically ill children.
    Bell M; Jackson E; Mi Z; McCombs J; Carcillo J
    Intensive Care Med; 1998 Oct; 24(10):1099-105. PubMed ID: 9840247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between the levels of cyclic cytidine 3':5'-monophosphate, cyclic guanosine 3':5'-monophosphate, and cyclic adenosine 3':5'-monophosphate in urines and leukocytes and the type of human leukemias.
    Scavennec J; Carcassonne Y; Gastaut JA; Blanc A; Cailla HL
    Cancer Res; 1981 Aug; 41(8):3222-7. PubMed ID: 6265079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclic nucleotides and catecholamines in rheumatoid arthritis.
    Trang LE; Lövgren O; Norlund AE; Horn R; Walaas O
    Scand J Rheumatol; 1983; 12(2):171-6. PubMed ID: 6304870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
    Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of treadmill exercise on plasma and urinary cyclic adenosine 3'5'-monophosphate.
    Lin T
    Horm Metab Res; 1978 Jan; 10(1):50-1. PubMed ID: 204566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary excretion of cAMP and cGMP in bronchogenic carcinoma complicated by hypertrophic osteoarthropathy.
    Francini G; Nami R; Grossi A; Gennari C
    Panminerva Med; 1983; 25(1):19-21. PubMed ID: 6306543
    [No Abstract]   [Full Text] [Related]  

  • 52. Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
    Bamonti-Catena F; Peracchi M; Conte D; Cantalamessa L; Lorenzano E; Orsatti A; Salerno F
    Clin Chem Lab Med; 1998 Sep; 36(9):709-14. PubMed ID: 9804395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased urinary excretion of cyclic nucleotides in X-linked hypophosphatemic (Hyp) mice.
    Kiebzak GM; Meyer RA; Mish PM
    Experientia; 1981; 37(9):978-9. PubMed ID: 6271566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma.
    Siddle K; Davies CJ; Shetty KJ; Elkeles RS
    Clin Sci Mol Med; 1976 Jun; 50(6):487-91. PubMed ID: 179751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW
    J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.
    Jackson EK; Mi Z; Janesko-Feldman K; Jackson TC; Kochanek PM
    Am J Physiol Regul Integr Comp Physiol; 2019 Jun; 316(6):R783-R790. PubMed ID: 30789788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in cancer tissue, plasma and urine of esophageal cancer patients].
    Zhao CY
    Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):175-7. PubMed ID: 2990838
    [No Abstract]   [Full Text] [Related]  

  • 58. Urinary excretion of cyclic-AMP and cyclic-GMP in allergic children throughout seven months of hyposensitization treatment.
    Castellote MC; Muñoz Lopez F; Barbera G; Torralba A
    Ann Allergy; 1981 May; 46(5):281-3. PubMed ID: 6263134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The 24-h urinary cyclic adenosine 3', 5' monophosphate/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function.
    Caniggia A; Nuti R; Galli M
    J Endocrinol Invest; 1981; 4(3):281-7. PubMed ID: 6274946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cyclic nucleotide excretion in lympholeukemia, polycythemia vera and malignant neoplasms].
    Ermil'chenko GV; Malykhina LS; Fedorov NA; Sevast'ianova MG; Krasiukova LI
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):40-3. PubMed ID: 219428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.